426 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
SNY Sanofi $43.75 $109.14B Downtrend
Article Searches
Top Ranked Income Stocks to Buy for January 21st http://www.zacks.com/commentary/206793/top-ranked-income-stocks-to-buy-for-january-21st?cid=CS-ZC-FT-206793 Jan 21, 2019 - Top Ranked Income Stocks to Buy for January 21st
Top Ranked Income Stocks to Buy for January 18th http://www.zacks.com/commentary/206041/top-ranked-income-stocks-to-buy-for-january-18th?cid=CS-ZC-FT-206041 Jan 18, 2019 - Top Ranked Income Stocks to Buy for January 18th
Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY http://www.zacks.com/stock/news/348355/pharma-stock-roundup-regulatory-updates-in-focus-at-pfe-bmy-rhhby-sny?cid=CS-ZC-FT-348355 Jan 18, 2019 - Pfizer's (PFE) tafamidis application gets FDA's priority review. Regulatory updates for Roche's (RHHBY) and Bristol-Myers'(BMY) cancer combination drugs in focus.
Regeneron, Sanofi Restructure Immuno-Oncology Collaboration http://www.zacks.com/stock/news/346110/regeneron-sanofi-restructure-immuno-oncology-collaboration?cid=CS-ZC-FT-346110 Jan 07, 2019 - Regeneron (REGN) amends its existing agreement with Sanofi and selects two clinical-stage bispecific antibodies for the ongoing collaboration.
Emergent (EBS) Files Application for Emergency Use of NuThrax http://www.zacks.com/stock/news/345130/emergent-ebs-files-application-for-emergency-use-of-nuthrax?cid=CS-ZC-FT-345130 Dec 31, 2018 - Emergent (EBS) submits an application to the FDA for the emergency use of its anthrax vaccine candidate, NuThrax.
Sanofi Wins FDA Nod for Pediatric Hexavalent Combo Vaccine http://www.zacks.com/stock/news/344768/sanofi-wins-fda-nod-for-pediatric-hexavalent-combo-vaccine?cid=CS-ZC-FT-344768 Dec 27, 2018 - Sanofi (SNY) gains an FDA approval for its pediatric hexavalent combination vaccine, Vaxelis.
The Zacks Analyst Blog Highlights: Apple, Microsoft, Mastercard, Sanofi and Dominion Energy http://www.zacks.com/stock/news/344560/the-zacks-analyst-blog-highlights-apple-microsoft-mastercard-sanofi-and-dominion-energy?cid=CS-ZC-FT-344560 Dec 26, 2018 - The Zacks Analyst Blog Highlights: Apple, Microsoft, Mastercard, Sanofi and Dominion Energy
5 Top Drug/Biotech Merger & Acquisition Targets for 2019 http://www.zacks.com/stock/news/342034/5-top-drug-biotech-merger-acquisition-targets-for-2019?cid=CS-ZC-FT-342034 Dec 10, 2018 - Here are five stocks that are attractive and most likely to be takeout targets in 2019.
4 Big Pharma Stocks to Add to Your Portfolio in December http://www.zacks.com/stock/news/339943/4-big-pharma-stocks-to-add-to-your-portfolio-in-december?cid=CS-ZC-FT-339943 Nov 29, 2018 - The large-cap pharma industry has been on a strong footing lately. Here are four stocks from the space that investors may consider betting on.
Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs http://www.zacks.com/stock/news/339189/pharma-stock-roundup-cancer-approvals-for-pfe-abbv-chmp-nod-for-several-drugs?cid=CS-ZC-FT-339189 Nov 23, 2018 - FDA grants approval to Pfizer's (PFE) new cancer drug and label expansion of AbbVie/Roche's Venclexta. CHMP gives nod to several drugs

Pages: 12345678910...43

<<<Page 5>